Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman – and Martin Shkreli
03:32pm, Monday, 06'th Nov 2023
Kristopher Koeller relies on two daily medications to keep his blood pressure under control. They're both generics that have been on the market for decades–the kind of drugs that should be cheap.
Long-Term Winners: Ray Dalio's Top 3 Stock Recommendations for a Prosperous Future
01:30pm, Monday, 06'th Nov 2023
Amid the intricacies in the investment realm, Ray Dalio stock picks continue to resonate with both budding and seasoned investors. Since he stepped down from active leadership at Bridgewater Associate
5 Relatively Secure And Cheap Dividend Stocks To Invest In - November 2023
09:00am, Saturday, 04'th Nov 2023
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever
05:30am, Saturday, 04'th Nov 2023
Companies with a track record of dividend increases have shown rewarding shareholders is a priority. If those companies also have strong free cash flow, they may offer you a long future of dividend pa
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:33am, Friday, 03'rd Nov 2023
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
GSK Beats on Q3 Earnings and Sales, Raises 2023 Guidance
12:47pm, Wednesday, 01'st Nov 2023
GSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The company raises guidance for earnings and sales on the back of strong RSV vaccine sales.
3 Dividend Kings Whose Growth Streaks Could Break Before 2030
10:12am, Wednesday, 01'st Nov 2023
Johnson & Johnson, Altria, and 3M have all been increasing their dividend payments for more than 50 consecutive years. These companies all face issues that could put those streaks at risk in the futur
Investor patience tested as pharmaceutical stocks take a tumble
06:07am, Wednesday, 01'st Nov 2023
The Health Care Select Sector SPDR Fund NYSEARCA: XLV was down 3.81% in the past month and 8.03% in the past three months. The latest round of pharmaceutical stock earnings isn't helping sector perfor
U.S. FDA approves Amgen's biosimilar vesrion of J&J's Stelara
06:32pm, Tuesday, 31'st Oct 2023
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis treatment Stelara for multiple inflammatory diseases.
J&J stock down as business unit mulls talc-related bankruptcy
08:12am, Tuesday, 31'st Oct 2023
Shares of Johnson & Johnson NYSE: JNJ slid 4.84% lower the week ending October 27, as the company's subsidiary LTL Management is facing a raft of lawsuits pertaining to talc in its baby powder.
Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime
05:03am, Saturday, 28'th Oct 2023
Johnson & Johnson and NextEra Energy can anchor any portfolio. Johnson & Johnson's investments in science and innovation have paid big dividends over the years.
Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now
05:00am, Saturday, 28'th Oct 2023
These two market leaders offer you solid earnings prospects and the promise of dividend growth. They both look cheap today, considering their track records and long-term potential.
Johnson & Johnson produces documents in DoJ civil investigation of eye products
05:24pm, Friday, 27'th Oct 2023
Johnson & Johnson has begun providing documents and information in response to a civil investigation by the U.S. Department of Justice related to free and discounted eye surgery products, the company
10 High-Yield Dividend Aristocrats Perfect For What's Coming Next
07:35am, Friday, 27'th Oct 2023
Investors are worried about soaring interest rates, a pending government shutdown, wars around the world, and a recession looming next year. History is very clear, market timing is the WORST thing you
Should You Pick Johnson & Johnson Stock After A 6% Fall In A Month Despite Upbeat Q3?
09:00am, Wednesday, 25'th Oct 2023
Johnson & Johnson (NYSE: JNJ) reported its Q3 results last week, with revenues and earnings beating the street estimates.
